Health & Nutrition
We're exiting our position in a health-care stock to raise...
We're cutting loose the smallest position in our portfolio.
What About Millet and Diabetes?
What were the remarkable results of a crossover study randomizing hundreds of people...
Healthy Returns: AstraZeneca cholesterol pill shows promise...
AstraZeneca's new cholesterol pill is showing promise, while the FTC urged a potential...
Hims & Hers shares rise as company adds new weight-loss...
Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide...
Europe's pharma industry braces for tariffs as carve-out...
Europe's pharmaceutical sector is bracing for the potential impact of U.S. tariffs...
Don't overlook the impact of pharma tariffs, says an analyst....
The drug stock is higher over the past month while the S&P 500 has pulled back...
Eli Lilly sues two pharmacies making copycat Zepbound,...
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide,...
APRIL FOOL’S! THERE’S NO QUEST CONDIMENTS (YET)!
APRIL FOOL’S! Okay, so we’re not really launching a line of Quest Protein Condiments....
Is Millet a Nutritious Grain?
Millet isn’t the name of a specific grain, but a generic term that applies to a...
23andMe bankruptcy: With America's DNA put on sale, market...
Genetic testing company 23andMe's bankruptcy has led to a new consumer privacy issue:...
